Clinical trials recruiting in Amadora, Portugal
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 4Not applicable 3
Conditions recruiting in Amadora, Portugal
Recruiting trials in Amadora, Portugal
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
- PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
- Validation of the C-mo System - Cough Monitoring
Common questions
How many clinical trials are recruiting in Amadora, Portugal?
8 recruiting trials have at least one study site in Amadora, Portugal.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.